Best Options Strategy for IONS
Looking for the best options strategy for Ionis Pharmaceuticals, Inc. (IONS)? There is no single answer — the right play depends on your outlook, your risk tolerance and current implied volatility. Below, our free engine shows the highest-scoring defined-risk strategy on the live IONS option chain right now, and a simple map from your view on IONS to the strategy that fits it. Model any of them in the calculator before you trade.
About Ionis Pharmaceuticals, Inc.
# About Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals is a biotechnology company that develops and commercializes medicines designed to target RNA. The company's approved products address rare genetic and neurological diseases. SPINRAZA treats spinal muscular atrophy in children and adults, while WAINUA and TEGSEDI address hereditary transthyretin amyloidosis affecting the nervous system. The company also markets TRYNGOLZA for a rare lipid disorder called familial chylomicronemia syndrome, DAWNZERA to prevent attacks of hereditary angioedema, QALSODY for amyotrophic lateral sclerosis, and WAYLIVRA for lipid metabolism disorders. Beyond its marketed drugs, Ionis maintains a substantial pipeline of investigational medicines, including several in Phase 3 trials targeting conditions like severe hypertriglyceridemia, Alexander disease, and other rare neurological disorders.
The company generates revenue primarily from sales of its approved medications in the United States market. Ionis operates partnerships to extend its reach and capabilities, including a strategic collaboration with Biogen focused on neurological disease treatments. The company's business model relies on…
Today's top-scoring strategy for IONS
Our engine ranks defined-risk strategies on the live IONS chain by probability of profit and risk/reward, then surfaces the best-scoring one. It is an educational illustration, not advice.
| Action | Qty | Type | Strike | Premium |
|---|---|---|---|---|
| Buy | 1× | PUT | $42.5 | $0.35 |
| Sell | 1× | PUT | $52.5 | $3.25 |
| Sell | 1× | CALL | $52.5 | $3.15 |
| Buy | 1× | CALL | $62.5 | $0.72 |
Simulazione
Simulazione prospettica di 6,000 traiettorie di prezzo lognormali fino alla scadenza — non è un backtest storico.
Analisi della strategia
Greche vs prezzo
Prezzo × volatilità (oggi)
| −30% | −15% | IV | +15% | +30% | |
|---|---|---|---|---|---|
| $66 | −$341 | −$305 | −$279 | −$262 | −$253 |
| $63 | −$257 | −$229 | −$214 | −$208 | −$209 |
| $61 | −$148 | −$141 | −$145 | −$154 | −$167 |
| $58 | −$29 | −$53 | −$80 | −$106 | −$132 |
| $55 | $70 | $16 | −$32 | −$72 | −$108 |
| $53 | $113 | $44 | −$13 | −$61 | −$101 |
| $50 | $78 | $17 | −$34 | −$78 | −$115 |
| $47 | −$32 | −$63 | −$94 | −$124 | −$151 |
| $45 | −$181 | −$177 | −$182 | −$192 | −$204 |
| $42 | −$318 | −$293 | −$278 | −$270 | −$268 |
| $39 | −$409 | −$383 | −$361 | −$344 | −$333 |
Live scan from 2026-07-22 · quotes delayed ~15 minutes
Backtest storico: come si sarebbe comportata una Iron Butterfly su IONS
Abbiamo simulato in modo approssimativo una Iron Butterfly su IONS che avresti aperto ripetutamente nell'ultimo anno (93 ingressi storici, ciascuno mantenuto fino alla scadenza), con i premi d'ingresso modellati tramite Black-Scholes. Ecco come sarebbe andata sulla reale storia dei prezzi di IONS — un backtest didattico, non una previsione dei rendimenti futuri.
In via approssimativa: i premi d'ingresso sono modellati con Black-Scholes sulla base della volatilità realizzata trailing, mantenuti fino alla scadenza e regolati contro il reale prezzo di chiusura storico. Fill reali, volatilità implicita e slippage differiscono — consideralo come contesto indicativo, non come rendimento esatto.
Implied volatility
IONS is currently trading with elevated implied volatility, so its options carry richer premiums. On the options we scanned that was around 52% implied volatility, and higher implied volatility means richer premiums and wider expected moves.
Options on IONS currently price in about 52% implied volatility, versus roughly 89% the stock has actually realised over the past month. That makes options relatively cheap — an edge for strategies that buy premium, such as long calls, long puts and debit spreads.
Off that volatility, the options market is pricing a move of about ±$7,8 (±15%) in IONS by 2026-08-21 — a range of roughly $44,83 to $60,42. Strikes inside that band hold most of the premium and see most of the action.
Across strikes, downside puts on IONS trade at a higher implied volatility than upside calls — the market is paying up for crash protection. That skew favours selling put spreads or buying calls over symmetric trades.
In evidenza dalla option chain di IONS: open interest, volume e skew
La option chain live di IONS mostra un rapporto put/call sull'open interest di 0.32 (bullish-leaning (more calls)), con una volatilità implicita at-the-money intorno al 52.4%. L'open interest si concentra sulla call a 77.5 — un classico "muro" di resistenza — e sulla put a 50, un "muro" di supporto: esattamente gli strike a cui gli scrittori di opzioni sono più esposti verso la scadenza.
Istantanea di open interest, volume e volatilità implicita per la scadenza scansionata più vicina — contesto, non un segnale di trading.
Insider trading su IONS (SEC Form 4)
Operazioni degli insider sul mercato aperto relative a IONS negli ultimi sei mesi circa, tratte dalle comunicazioni SEC Form 4. Gli acquisti sul mercato aperto sono il segnale più raro e più forte — le vendite di routine effettuate nell'ambito di piani prestabiliti sono frequenti, quindi leggi un dato di vendita netta tenendolo presente.
| Insider | Azione | Azioni | Valore | Data |
|---|---|---|---|---|
| Kordasiewicz Holly B. | Vendita | 362 | $31K | 2026-07-07 |
| Diaz Allene M. | Vendita | 10.111 | $864K | 2026-07-07 |
| BENNETT C FRANK | Vendita | 15.000 | $1.3M | 2026-07-07 |
| BENNETT C FRANK | Vendita | 5536 | $463K | 2026-07-07 |
| KLEIN JOSEPH III | Vendita | 11.419 | $903K | 2026-07-01 |
| KLEIN JOSEPH III | Vendita | 99 | $8K | 2026-07-01 |
Fonte: comunicazioni SEC Form 4 tramite Finnhub. Solo acquisti (P) e vendite (S) sul mercato aperto — assegnazioni, esercizi di opzioni, donazioni e ritenute fiscali sono esclusi. Contesto informativo, non consulenza sugli investimenti.
Liquidity and tradeability
IONS options are thinly traded, with wide bid-ask spreads around 15,8% near the money that eat into any edge — favour simple single-leg or tight defined-risk trades, and always use limit orders.
Earnings & IV crush
IONS's next earnings report is due around 29 luglio 2026. Options that expire after it price in a binary move, so their implied volatility is elevated and usually collapses right after the announcement — an "IV crush". If your expiration falls before this date, the trade sidesteps the event.
With earnings roughly 7 days out, IONS's 52% implied volatility is inflated by event premium — and it usually collapses the moment results drop ("IV crush"). That rewards defined-risk premium sellers when the move stays muted, and punishes option buyers who paid the inflated price. Keep size small and risk defined through the report.
Key figures
- Market cap
- $8.9B
- Beta (vs market)
- 0.36
- 52-week range
- $40.03–$86.74 (27% up the range)
- Short interest
- 14.0% of float · 8.6 days to cover
With 14.0% of IONS's float sold short, squeeze and gap risk are elevated — one reason its options can stay expensive.
Other strong setups for IONS
If your view on IONS differs, these also scored well in the latest scan:
How to choose an options strategy for IONS
Start with your outlook on IONS, then match it to a defined-risk structure. Here are the most common choices and when each makes sense:
Bullish
Buy a call for leverage with capped risk, or a bull call spread to lower the cost and breakeven when you have a target price.
Long Call → Bull Call Spread →Bearish
Buy a put to profit from a decline with defined risk, or a bear put spread to cheapen the trade when you expect a measured move down.
Long Put → Bear Put Spread →Neutral
Sell an iron condor to collect premium while IONS stays between two strikes, or write a covered call against shares you already own.
Iron Condor → Covered Call →⧉ Embed this free calculator on your site →
How we pick the best strategy
For each ticker we pull the live option chain, build every supported strategy around the at-the-money strikes, and score them on probability of profit, risk/reward and capital efficiency — favouring defined-risk structures where the maximum loss is known up front. Methodology →
Open IONS in the free calculator →
Domande frequenti
What is the best options strategy for IONS?
It depends on your outlook. Bullish traders often use a long call or bull call spread on IONS; bearish traders a long put or bear put spread; neutral traders an iron condor or covered call. Our live scan above shows the current highest-scoring defined-risk play.
Are IONS options liquid enough to trade?
Ionis Pharmaceuticals, Inc. (IONS) is among the most actively-traded US options, which usually means tight bid/ask spreads and plenty of strikes and expirations — though you should always check the open interest and spread on the exact contract.
How much money do I need to trade IONS options?
Buying a single IONS call or put can cost as little as the premium (often one to a few hundred dollars), while income strategies like a cash-secured put need enough capital to buy 100 shares if assigned.
Is this financial advice?
No. Everything here is educational and uses delayed, third-party data. It is not a recommendation to trade IONS or any security. Do your own research.
Cosa fa Ionis Pharmaceuticals, Inc.?
Ionis Pharmaceuticals, Inc. (IONS) opera nel settore Biotechnology. La sezione "Informazioni su Ionis Pharmaceuticals, Inc." qui sopra offre un quadro più completo di ciò che fa l'azienda e di come genera profitti.
Ionis Pharmaceuticals, Inc. paga dividendi?
Qui non mostriamo un rendimento da dividendo confermato per Ionis Pharmaceuticals, Inc., quindi consideralo incerto: prima di scrivere delle call controlla il dividendo attuale e la data di stacco cedola (ex-dividend) presso il tuo broker — una data di stacco imminente può innescare un'assegnazione anticipata sulle call scritte in-the-money.
Quando Ionis Pharmaceuticals, Inc. pubblica gli utili?
I prossimi utili di Ionis Pharmaceuticals, Inc. sono attesi intorno al 29 luglio 2026. La volatilità implicita di solito sale in avvicinamento alla pubblicazione e crolla bruscamente dopo (IV crush) — un aspetto importante per qualsiasi posizione in opzioni che mantieni oltre quella data.
Tickers related to IONS
Comparing IONS with similar names can help you choose the best options strategy:
Informazioni sull’azienda
- Sede
- 2855 Gazelle Court, Carlsbad, CA, 92010, United States
- Settore
- Biotechnology
- Dipendenti
- 1402
- CEO
- Dr. Brett P. Monia Ph.D.
- Telefono
- 760 931 9200
- Sito web
- www.ionis.com
- Relazioni con gli investitori
- ir.isispharm.com/phoenix.zhtml?c=222170&p=irol-irhome
Best Options Strategy by Ticker →
Solo per uso didattico. Le quotazioni sono ritardate di circa 15 minuti e nulla di ciò che è riportato qui è consulenza finanziaria. Il trading di opzioni comporta un rischio sostanziale di perdita. Privacy · Terms.